Boric acid
Producer: RUP of Belmedpreparata Republic of Belarus
Code of automatic telephone exchange: D08AD
Release form: Firm dosage forms. Powder for external use.
General characteristics. Structure:
Active ingredient: 2 g, 10 g or 20 g of boric acid.
Pharmacological properties:
Pharmacodynamics. Boric acid has antiseptic and fungistatic activity. Coagulates proteins (including fermental) a microbic cell, breaks permeability of a cellular cover. 5% aqueous solution inhibit processes of phagocytosis, 2 – 4% solution detain growth and development of bacteria. Renders weak irritant action on granulyatsionny fabrics.
Pharmacokinetics. It is absorbed through the injured skin, a wound surface, mucous membranes in a digestive tract (at accidental intake). Especially well gets through skin and mucous membranes at children of early age. At repeated receipt renal failures, a metabolic acidosis, arterial hypotension can develop in an organism of the child.
Boric acid can collect in bodies and body tissues. It is removed slowly (at repeated receipt kumulirut).
Indications to use:
Dermatitis, pyoderma, the becoming wet eczema, an intertrigo.
Route of administration and doses:
Appoint at skin diseases (the becoming wet eczema, dermatitis, a pyoderma, an intertrigo) of 3% aqueous solution for lotions. To dissolve 2 g of powder in 65-70 ml of hot boiled water (to dissolve 1/2 teaspoons of powder in 80-90 ml of hot boiled water), to cool solution to room temperature and to use for lotions.
Features of use:
It is not necessary to apply drugs of boric acid on extensive body surfaces, and also to use for washing of cavities. Do not use drugs of boric acid at acute inflammatory diseases of the sites of skin covered with hair.
Side effects:
The irritation of sensitive skin is possible.
Interaction with other medicines:
At external use interaction cases with other medicines are not described.
Contraindications:
Hypersensitivity to drug, a renal failure, the pregnancy period, children's age, processing of mammary glands before feeding of the child.
Overdose:
At external use of overdose it was not noted so far.
Issue conditions:
Without recipe
Packaging:
Powder for external use of 2 g, 10 g or 20 g in a package.